💨 Abstract

Purdue Pharma's $7 billion-plus settlement for opioid lawsuits will be reviewed by a judge. If approved, it will go to a vote by affected groups by September 30. The settlement aims to avoid trials and address the opioid crisis, with most funds going to governments and some directly to victims. The Sackler family, who own the company, will give up ownership, and their liability for lawsuits will be retained. The final approval hearing is scheduled for November.

Courtesy: WTOP Staff